Terms: = Thyroid cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Prognosis
125 results:
1. ttf-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S; Dernbach G; Dragomir MP; Schlachtenberger G; Boschung K; Friedrich C; Standvoss K; Ruff L; Anders P; Grohé C; Randerath W; Merkelbach-Bruse S; Quaas A; Heldwein M; Keilholz U; Hekmat JK; Rückert C; Büttner R; Horst D; Klauschen F; Frost N
Eur J Cancer; 2024 Jan; 197():113474. PubMed ID: 38100920
[TBL] [Abstract] [Full Text] [Related]
2. Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants.
Ohishi Y; Nakanishi Y; Hirotani Y; Suzuki A; Tanino T; Nishimaki-Watanabe H; Kobayashi H; Nozaki F; Ohni S; Tang X; Hayashi K; Nakagawa Y; Shimizu T; Tsujino I; Takahashi N; Gon Y; Masuda S
Thorac Cancer; 2024 Jan; 15(1):89-93. PubMed ID: 38093515
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
4. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between brain metastasis and thyroid transcription factor 1.
Kut E; Menekşe S
Sci Rep; 2023 Feb; 13(1):1945. PubMed ID: 36732655
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical characteristics of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and review.
Guo H; Zhang Z; Huang C; Qiu J; Qu X
Medicine (Baltimore); 2023 Jan; 102(4):e32655. PubMed ID: 36705380
[TBL] [Abstract] [Full Text] [Related]
7. NUTM1 -rearranged Carcinoma of the thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract] [Full Text] [Related]
8. Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma.
Roh H; Lee SY; Lee J; Hwang SY; Kim JH
J Neurosurg; 2023 Mar; 138(3):663-673. PubMed ID: 35962961
[TBL] [Abstract] [Full Text] [Related]
9. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract] [Full Text] [Related]
10. Effects of Anti-cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary thyroid cancer.
Yun HJ; Kim M; Kim SY; Fang S; Kim Y; Chang HS; Chang HJ; Park KC
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054884
[TBL] [Abstract] [Full Text] [Related]
11. CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis.
Yang Y; Yuan G; Xie H; Wei T; Zhu D; Zhu Y; Zheng S
J Int Med Res; 2021 Oct; 49(10):3000605211013199. PubMed ID: 34637340
[TBL] [Abstract] [Full Text] [Related]
12. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
[TBL] [Abstract] [Full Text] [Related]
13. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
Zheng ZG; Sun WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
[TBL] [Abstract] [Full Text] [Related]
14. SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Nambirajan A; Singh V; Bhardwaj N; Mittal S; Kumar S; Jain D
Arch Pathol Lab Med; 2021 Jan; 145(1):90-98. PubMed ID: 33367658
[TBL] [Abstract] [Full Text] [Related]
15. Functional and clinical significance of ROR1 in lung adenocarcinoma.
Schiavone G; Epistolio S; Martin V; Molinari F; Barizzi J; Mazzucchelli L; Frattini M; Wannesson L
BMC Cancer; 2020 Nov; 20(1):1085. PubMed ID: 33172431
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
J Cancer Res Ther; 2020; 16(4):737-744. PubMed ID: 32930112
[TBL] [Abstract] [Full Text] [Related]
17. [Analysis of Correlation between ttf-1 and Sensitivity to First-line Chemotherapy and prognosis in Patients with Small Cell Lung cancer].
Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
[TBL] [Abstract] [Full Text] [Related]
18. Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma.
Da Cruz V; Yvorel V; Casteillo F; Tissot C; Luchez A; Bayle-Bleuez S; Fournel P; Tiffet O; Péoc'h M; Forest F
Lung Cancer; 2020 Sep; 147():77-82. PubMed ID: 32682188
[TBL] [Abstract] [Full Text] [Related]
19. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
[TBL] [Abstract] [Full Text] [Related]
20. Long Non-Coding RNA NANCI/nkx2-1 Duplex Impacts prognosis in Stage I Non-Small-Cell Lung cancer.
Moisés J; Navarro A; Castellano JJ; Viñolas N; Molins L; Canals J; Han B; Martín J; Ramirez J; Frigola G; Marrades RM; Monzó M
Arch Bronconeumol (Engl Ed); 2020 Oct; 56(10):630-636. PubMed ID: 32178834
[TBL] [Abstract] [Full Text] [Related]
[Next]
